HyperLink
SEARCH:
Search

 
For Information on Physicians and Services, call 1-800-926-UCSD

About Us
Appointments
Care Centers and Departments
Blood & Marrow Transplant
About the BMT Process
BMT Options | Types of BMT
Conditions Treated with BMT
Drug Therapy
Program Accreditation
Brain Tumor Unit
Breast Cancer Unit
Cancer Genetics Unit
Gastrointestinal Cancer Unit
Gynecological Cancer Unit
Head & Neck Cancer Unit
HIPEC - Heated Intraperitoneal Chemotherapy
Imaging/Diagnostic Radiology
Infusion Center
Laboratory & Phlebotomy
Leukemias & Lymphomas
Lung Cancer Unit
Melanoma Unit
Multispecialty Clinic
Pancreatic Cancer Program
Pharmacy
Procedure Suite
Radiation Oncology
Soft Tissue Tumor Unit
Urologic Cancer Unit
Clinical Trials
Health Information
New Patient Orientation
Prevention Programs
Support Services for Patients & Families
Types of Cancer

Drug Therapy for BMT

After a Bone Marrow Transplant procedure, patients are required to follow a drug therapy regimen that may involve:

  • Anti-emetics - Patients may continue on anti-emetic therapy for several days following their transplant until appetite stabilizes.
  • Immunosuppressives - For patients of the allogeneic stem cell transplant procedure, cyclosporine or FK506 is most commonly prescribed.  Patients may be placed on Prednisone or Solumederol if "graft vs. host disease" (GVHD) develops.
  • Antibiotics - Since patients are at risk for developing a significant blood-borne infection, most patients are placed on prophylactic antibiotics.  A special diet for neutropenic patients and other precautions to reduce risk of infection will be followed.